Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metal drugs become targeted.
Fuereder T, Berger W. Fuereder T, et al. Among authors: berger w. ESMO Open. 2017 Aug 17;2(3):e000239. doi: 10.1136/esmoopen-2017-000239. eCollection 2017. ESMO Open. 2017. PMID: 29225925 Free PMC article. No abstract available.
Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology.
Prager GW, Unseld M, Waneck F, Mader R, Wrba F, Raderer M, Fuereder T, Staber P, Jäger U, Kieler M, Bianconi D, Hoda MA, Baumann L, Reinthaller A, Berger W, Grimm C, Kölbl H, Sibilia M, Müllauer L, Zielinski C. Prager GW, et al. Among authors: berger w. Oncotarget. 2019 Jan 29;10(9):942-952. doi: 10.18632/oncotarget.26604. eCollection 2019 Jan 29. Oncotarget. 2019. PMID: 30847023 Free PMC article.
Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI.
Kieler M, Unseld M, Bianconi D, Waneck F, Mader R, Wrba F, Fuereder T, Marosi C, Raderer M, Staber P, Berger W, Sibilia M, Polterauer S, Müllauer L, Preusser M, Zielinski CC, Prager GW. Kieler M, et al. Among authors: berger w. ESMO Open. 2019 Jul 17;4(4):e000538. doi: 10.1136/esmoopen-2019-000538. eCollection 2019. ESMO Open. 2019. PMID: 31423337 Free PMC article.
Anticancer metal drugs and immunogenic cell death.
Terenzi A, Pirker C, Keppler BK, Berger W. Terenzi A, et al. Among authors: berger w. J Inorg Biochem. 2016 Dec;165:71-79. doi: 10.1016/j.jinorgbio.2016.06.021. Epub 2016 Jun 16. J Inorg Biochem. 2016. PMID: 27350082 Review.
Metal Drugs and the Anticancer Immune Response.
Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W. Englinger B, et al. Among authors: berger w. Chem Rev. 2019 Jan 23;119(2):1519-1624. doi: 10.1021/acs.chemrev.8b00396. Epub 2018 Nov 29. Chem Rev. 2019. PMID: 30489072 Review.
Resistance against novel anticancer metal compounds: differences and similarities.
Heffeter P, Jungwirth U, Jakupec M, Hartinger C, Galanski MS, Elbling L, Micksche M, Keppler B, Berger W. Heffeter P, et al. Among authors: berger w. Drug Resist Updat. 2008 Feb-Apr;11(1-2):1-16. doi: 10.1016/j.drup.2008.02.002. Epub 2008 Apr 3. Drug Resist Updat. 2008. PMID: 18394950 Review.
Anticancer activity of metal complexes: involvement of redox processes.
Jungwirth U, Kowol CR, Keppler BK, Hartinger CG, Berger W, Heffeter P. Jungwirth U, et al. Among authors: berger w. Antioxid Redox Signal. 2011 Aug 15;15(4):1085-127. doi: 10.1089/ars.2010.3663. Epub 2011 May 11. Antioxid Redox Signal. 2011. PMID: 21275772 Free PMC article. Review.
1,144 results